IMUX — Immunic Inc · $79.5M cap

Immunic Inc (IMUX) is a biotechnology company listed on US.

Use this IMUX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IMUX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IMUX SEC filings page. Lician reads the product cache first so this HTML stays unique to Immunic Inc even when a live quote feed is slow.

Immunic Inc latest statements (FY2025)

Latest cached year on this hub. Full IMUX income, balance, and cash tables.

  • Revenue$0
  • Net Income-$97.2M
  • Total Assets$24.1M
  • Total Debt$0
  • Free Cash Flow-$86.0M

IMUX recent filings